The use of mathematical modelling studies for evidence synthesis and guideline development: a glossary. by Porgo, Teegwendé V et al.
 This article has been accepted for publication and undergone full peer review but has not 
been through the copyediting, typesetting, pagination and proofreading process which may 
lead to differences between this version and the Version of Record. Please cite this article as 
doi: 10.1002/jrsm.1333 
 
This article is protected by copyright. All rights reserved. 
The use of mathematical modelling studies for evidence synthesis and guideline 
development: a glossary  
 
Teegwendé V. Porgo,a,b Susan L. Norris,b Georgia Salanti,c Leigh F. Johnson,d Julie A. 
Simpson,e Nicola Low,c Matthias Egger,c,d Christian L. Althausc* 
 
aPopulation Health and Optimal Health Practices Research Unit, Department of Social and 
Preventative Medicine, Faculty of Medicine, Université Laval, Quebec, Canada 
bDepartment of Information, Evidence and Research, World Health Organization, Geneva, 
Switzerland 
cInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland 
dCentre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape 
Town, South Africa 
eCentre for Epidemiology and Biostatistics, Melbourne School of Population and Global 
Health, University of Melbourne, Melbourne, Australia 
 
*Correspondence to: Christian L. Althaus, Institute of Social and Preventive Medicine, 
University of Bern, Bern, Switzerland. 
Email: christian.althaus@alumni.ethz.ch 
 
Abstract 
 
Mathematical modelling studies are increasingly recognised as an important tool for evidence 
synthesis and to inform clinical and public health decision-making, particularly when data 
from systematic reviews of primary studies do not adequately answer a research question.  
However, systematic reviewers and guideline developers may struggle with using the results 
of modelling studies, due at least in part to the lack of a common understanding of concepts 
and terminology between evidence synthesis experts and mathematical modellers.  The use of 
a common terminology for modelling studies across different clinical and epidemiological 
research fields that span infectious and non-communicable diseases will help systematic 
reviewers and guideline developers with the understanding, characterisation, comparison and 
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use of mathematical modelling studies. This glossary explains key terms used in 
mathematical modelling studies that are particularly salient to evidence synthesis and 
knowledge translation in clinical medicine and public health. 
 
Keywords: Mathematical modelling studies; evidence synthesis; knowledge translation; 
guidelines; glossary 
 
1. Introduction 
Mathematical models are increasingly used to aid decision making in public health and 
clinical medicine.1,2 The results of mathematical modelling studies can provide evidence 
when a systematic review of primary studies does not identify sufficient studies to draw 
conclusions or to support a recommendation in a guideline, or when the studies that are 
identified do not apply to the specific populations of interest or do not provide data on long 
term follow up or on relevant outcomes. For example, mathematical models have been used 
to inform guideline recommendations about tuberculosis (TB) control in health care 
facilities,3 blood donor suitability with regard to human T-cell leukaemia virus type I (HTLV-
I) infection,4 and cancer screening.5,6 Mathematical modelling studies are frequently used to 
synthesize evidence from multiple data sources to address a clinical or public health question 
not directly addressed by a primary study. For example, a mathematical model was used to 
synthesise evidence obtained from virological, clinical, epidemiological and behavioural data 
to help determine optimal target populations for influenza vaccination programmes.7 Other 
examples are mathematical modelling studies that aim to predict the real-world drug 
effectiveness from randomised controlled trial (RCT) efficacy data (reviewed in Panayidou et 
al.7). 
The development of methods for incorporating mathematical modelling studies into evidence 
syntheses and clinical and public health guidelines is still at an early stage. Systematic 
reviewers and guideline developers struggle with questions about whether and how to include 
the results of mathematical modelling studies into a body of evidence. The review of 
mathematical modelling studies predicting drug-effectiveness from RCT data identified 
twelve studies using four different modelling approaches.7 Due to the varying use of key 
terminology between studies, and because certain terms can have different meanings in the 
literature, it was necessary to describe in the review each modelling approach in detail to 
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illustrate the differences between them. This effort highlights an important reason for the 
challenges in summarising the results of mathematical modelling studies. Researchers who 
develop and analyse mathematical models have different theoretical and practical 
backgrounds from systematic reviewers, guideline developers and policy-makers, which can 
result in a lack of a common understanding of concepts and terminology. These 
communication issues might result either in not using the findings of mathematical modelling 
studies in evidence synthesis and to inform decision-making, or accepting these findings 
without critical assessment.8 A glossary of commonly used terms in mathematical modelling 
studies that are relevant to evidence synthesis and to clinical and public health guideline 
development could improve the use of such studies. 
A mathematical model is a “mathematical framework representing variables and their 
interrelationships to describe observed phenomena or predict future events.”9 We define a 
mathematical modelling study as a study that uses mathematical modelling to address specific 
research questions, for example the impact of interventions in health care facilities to reduce 
nosocomial transmission of TB.10 For the modelling studies that are most relevant to evidence 
synthesis and clinical and public health decision-making, the framework of the mathematical 
model represents interrelationships among exposure risks, interventions, health outcomes and 
health costs (all of these are variables) where their interrelationships are typically described 
by the parameters of interest. Mathematical modellers can use different methods to specify 
these parameters; they can use theoretical values, values reported in the scientific literature, 
or estimate the parameters from data using methods from statistical modelling. There is some 
overlap between the terms ‘mathematical model’ and ‘statistical model’ and their uses. 
Contemporary mathematical modelling studies increasingly include one or more statistical 
modelling parts. In this glossary, we will consider statistical models as a class of 
mathematical models that are often integrated into complex mathematical modelling studies 
to relate the model output to data through a statistical framework. 
The goal of this glossary is to provide a common terminology for public health specialists 
who would like to incorporate the results of mathematical modelling studies in systematic 
reviews and in the development of guidelines. To identify the terms included in this glossary, 
we first made an exhaustive list of terms related to mathematical models. Terms were then 
selected based on discussions among experts attending the World Health Organization 
(WHO)’s Consultation on the development of guidance on how to incorporate the results of 
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modelling in WHO guidelines (Geneva, Switzerland, 26 April 2016). Experts included 
epidemiologists, statisticians, mathematical modellers, and public health specialists. The 
glossary is divided into three sections. In section 2, we define some key terms that can be 
used to characterise the scope of and approach to mathematical models, using examples from 
the field of infectious disease modelling. In section 3, we present a list of terms that are 
commonly used across different research fields in epidemiology to describe more detailed 
technical properties and aspects of mathematical models. In section 4, we first discuss how 
knowledge of the terms can help to assess whether a mathematical modelling study is 
appropriate for providing evidence for a specific question. We then use the example of the 
World Health Organization (WHO) guidelines for TB control in health care facilities3 to 
show how mathematical modelling studies can inform recommendations. For more specific 
definitions of terms that are primarily used in infectious disease modelling, we refer to the 
glossary by Mishra et al.11 Terms appearing in italics are defined in other entries of the 
glossary. 
 2. Terms used to define the scope of, and approaches to mathematical models  
Before one starts to assess and compare the results of different mathematical modelling 
studies with each other, it can be helpful to fit them into a larger picture.  Experts in 
systematic reviews and guideline developers need to be able to sort out which modelling 
studies are likely to help them draw a conclusion, formulate a recommendation, interpret the 
findings of another study, or understand the clinical or pathological background to a problem. 
Mathematical modelling studies can be characterised using several dichotomies that help to 
describe broad aspects, such as the scope and approach. Table 1 provides a list of some 
important model dichotomies, together with a brief definition, an example and their relevance 
to systematic reviews and guideline development. 
A fundamental distinction can be made between mechanistic and phenomenological models. 
Mechanistic models use mathematical terms to describe the real-world interactions among 
different model variables. The parameters governing these models typically have a physical, 
biological or behavioural interpretation. Infectious disease models, for example, can describe 
the movement of individuals within hospital wards, and how infections are transmitted upon 
physical contact between a susceptible and an infected person.10 These models have the 
advantage that specific interventions, such as infection prevention through quarantine or 
isolation, can be explicitly implemented. Phenomenological models, on the other hand, 
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describe the relationships among different model variables, consistent with fundamental 
theory, but not derived from first principles. Hence, this type of model does not attempt to 
describe or explain why and how certain model variables interact, but instead focuses on the 
functional relationship that best describes an observed phenomenon. Statistical models, such 
as regression models, are typically phenomenological and describe the statistical relationship 
or association between different model variables. 
A predictive model can forecast future events, such as the course of an epidemic in a given 
population under different scenarios, whereas a descriptive model describes and/or explains 
previously observed phenomena, such as the effectiveness of past interventions. Quantitative 
models provide a numerical estimation of an intervention effect on model variables, and 
therefore depend on high-quality data to inform the model parameters. Qualitative models 
are usually relatively simple models that only provide insights into the direction of an effect, 
but not its precise magnitude. Nevertheless, they can be used to thoroughly investigate the 
interrelationships between model variables and the influence of specific parameters on health 
outcomes (also see Analytic solution). Qualitative models can also be useful to explore the 
potential for unintended consequences of interventions beyond the direct intended effects that 
might have been observed in RCTs. Finally, an important model dichotomy distinguishes 
between what drives the results of mathematical modelling studies. Most mathematical 
models incorporate a combination of some underlying theory, model assumptions and data. 
The results of a theory-driven model are primarily based on a priori knowledge or 
assumptions about specific interrelationships, such as the effectiveness of a particular 
intervention, and are not directly inferred from data. Data-driven models infer their results 
primarily from data, and are not driven by theory or assumptions that are not well supported.   
 
3. Terms related to technical properties and aspects of mathematical models 
 
3.1. Technical terms related to model development and structure  
Once the mathematical modelling studies have been broadly characterised, and their purpose 
has been determined, it is important to gain a better understanding about some of the terms 
used to describe the technical aspects of the model used in a study. For example, has 
heterogeneity among different individuals been incorporated, or what simulation methods 
were used to obtain the model results? The following list includes some of the most 
frequently used terms in mathematical modelling studies in various fields of epidemiology. 
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The terms in Part 3.1 will help in assessing the technical aspects that relate to model 
development and structure. The terms in Part 3.2 are related to model calibration and 
validation. 
Agent-based model See Individual-based model. 
Analytic solution Relates the health outcomes directly to the model parameters using 
mathematical formulae.  Models that can be solved analytically are usually simple models, 
while more complex models typically require a computational (numerical) solution. 
Assumption In mathematical modelling studies, assumptions typically relate to the structure 
of the model and the supposed interrelationships of model variables. An important 
assumption in infectious disease models concerns the way in which individuals have contacts 
with each other. This could either be at random or involve some form of heterogeneity. In 
order to relate the model output to data via a statistical framework, one has to make 
additional assumptions about the way the data has been gathered and the expected random 
error. 
Compartmental model This model type stratifies the population into different 
compartments, such as different health states. Compartments are assumed to represent 
homogeneous sub-populations within which the entities being modelled – such as individuals 
or patients – have the same characteristics, for example the same sex, age, risk of infection or 
death. The model can account for the transition of entities between compartments (see State-
transition model).  
Computational (numerical) solution This describes the approach of solving a mathematical 
model using either deterministic or stochastic (see Monte Carlo methods) simulation 
techniques to iteratively calculate the model variables, which are often time-dependent, for a 
specific set of parameters. Iteratively calculating the model variables means updating the 
population characteristics at each time point based on the simulated population characteristics 
at previous time points. Computational solutions are used when the model is too complicated 
for deriving an analytic solution. 
Continuous-time model This is a dynamic model where time is treated as a continuous 
variable (in contrast to a discrete-time model), meaning that the state or value of all other 
variables (or health outcomes) can be calculated for any time point of interest.  
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Cycle length In a discrete-time model, cycle length represents the interval from one time 
point to the next, for example a specific number of days, weeks, months, or years.7  
Decision analytic model This term refers to mathematical models that synthesise available 
evidence to estimate health outcomes and guide decision making. The term is typically used 
in health economic analyses.  
Deterministic model This model type typically describes the average behaviour of a system 
(e.g., populations or sub-populations) without taking into account stochastic processes or 
chance events in single entities (e.g., individuals). Hence, such models are typically applied 
to situations with a large number of individuals where stochastic variation becomes less 
important and heterogeneity can be accounted for using various sub-populations. The 
parameters of a deterministic model are typically fixed, and a simulation always produces the 
same result. Deterministic models are typically easier to calibrate to data than stochastic 
models.11,12 
Discrete-time model This type of dynamic model treats time as a discrete variable (in 
contrast to a continuous-time model) and other variables (or health outcomes) can only 
change at specific time points.7   
Dynamic model A dynamic model contains at least one time-dependent variable.11 This type 
of model is used to describe and predict the course of health outcomes (e.g., infection 
incidence) over time when, for example, the exposure risk (e.g., infection prevalence) also 
changes over time.   
Heterogeneity In mathematical modeling studies, this typically describes the differences 
among individuals, or the variability across parameter values for a specific group of 
individuals, due to their demographic, biological or behavioural characteristics.  
Individual-based model This is a stochastic model representing individuals as discrete 
entities with unique characteristics. An individual-based model can be useful to accommodate 
heterogeneity in a given population. Individual-based models are also often referred to as 
agent-based or micro-simulation models. Whilst individual-based models can provide more 
realistic representations of a system, they can be difficult to parameterise because they 
require much more detailed knowledge, or assumptions, of how variables interact. The 
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stochastic nature of these models makes them computationally intensive and challenging to 
calibrate.  
Markov model A Markov model assumes that the future state of variables depends only on 
the current state, but not the previous states, of variables. For example, in a discrete-time 
Markov model, the number of new infected individuals is calculated based on the total 
number of infected individuals at the previous time step. 
Micro-simulation model See Individual-based model. 
Monte Carlo methods These are a class of computational methods that are based on random 
sampling. Monte Carlo methods are typically used to simulate stochastic models and are 
computationally intensive. 
Ordinary differential equations Equations that describe the change of a dependent variable 
with respect to an independent variable, based on differential calculus. For example, ordinary 
differential equations can be used to describe the increase and decrease of infected 
individuals in continuous time resulting from acquisition or clearance of infection. Ordinary 
differential equations are typically used for deterministic, compartmental models. 
Parameter A parameter is a quantity used to describe the interrelationships between model 
variables. For example, parameters can describe how long different individuals reside in 
different health states, or how likely they are to transmit a disease to another person. There 
are different methods to specify the value of parameters. Mathematical modellers can either 
choose theoretical values based on specific assumptions, or set the values based on literature 
reviews or model calibration. 
Parsimonious model In a parsimonious model, descriptive or predictive, the number of 
assumptions, parameters and variables is minimised. Parsimonious models are often 
relatively simple, but they can also become more complex, if they achieve the right balance 
between complexity and explanatory power. 
Population-based model A type of deterministic or stochastic model where individuals that 
share the same characteristics on average are being grouped into a single population or 
several sub-populations. In contrast, an individual-based model treats every individual as a 
single entity that can have unique characteristics. 
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State-transition model State-transition models assume that individuals can be in different 
(health) states and move (transition) between them.13 They are typically described using the 
framework of either Markov models or individual-based models. 
Static model In a static model, all variables are independent of time and constant. A static 
model typically describes the equilibrium of a system, and relates the model variables for a 
particular time point only. In contrast to dynamic models, this type of model cannot take into 
account time-dependent changes of exposure risks or health outcomes. Decision-tree models 
are static models.  
Stochastic model A type of model where the parameters, variables and/or the change in 
variables can be described by probability distributions. This type of model can account for 
process variability by taking into account the random nature of variable interactions, or can 
accommodate parameter uncertainty, and so may predict a distribution of possible health 
outcomes. Considering process variability can be particularly important when populations are 
small or certain events are very rare. Stochastic models are often simulated using Monte 
Carlo methods.  
Time horizon A time horizon denotes a chosen time at which point the effect of an 
intervention will be evaluated. The time horizon should reflect the health outcomes and the 
relevant intermediate and long-term effects of an intervention.1 
Variable Variables describe model elements such as exposure risks, interventions or health 
outcomes that can vary between settings or over time. The value of a dependent variable 
(e.g., number of infected individuals) changes in relation to an independent variable (e.g., 
time).  
 
3.2. Technical terms related to model calibration and validation 
Calibration Calibration is the process of adjusting model parameters such that the model 
output is in agreement with the data that are used for model development.14 The aim of 
calibration is to reduce parameter uncertainty in order to achieve high model credibility.  
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Credibility The credibility of a model refers to judgements about the degree to which the 
model provides trustworthy results. Several dimensions of credibility have been described, 
including validity, design, data analysis, reporting, interpretation and conflicts of interest.15  
Sensitivity analysis A range of techniques used to test the impact of the assumptions made 
about the parameters. The analysis can be done by changing one parameter (one-way, 
univariate) or simultaneously changing several parameters (multi-way, multivariate). The 
parameters selected for sensitivity analyses are thought to have an impact on the outcome of 
interest. In a deterministic sensitivity analysis, a parameter is assigned a limited number of 
values, while in a probabilistic sensitivity analysis each parameter is assigned a probability 
distribution, and parameter values are randomly sampled from these distributions.1,11  
Uncertainty analysis A range of techniques to determine the reliability of model results or 
predictions, accounting for uncertainty in model structure, input parameters and/or methods 
used for data analysis.11 Structural uncertainty relates to the extent to which the structure of 
the model captures the key features of the system16-18 and can be analysed by comparing the 
results of models with different structures. Parameter uncertainty stems from the model 
parameters that are used but whose true values are not known because of measurement error 
or an absence of evidence.16,18 This uncertainty can be analysed by examining model outputs 
for a range of values of the parameter. Methodological uncertainty arises when there are 
different methods for analysing or expressing model outputs. This term is used mostly in 
health economic modelling.  
Validation A term describing processes for assessing how well a model performs and how 
applicable the results are to a particular situation.19 There are five main types of validation: 
face validation (subjective expert judgement about how well the model represents the 
problem it addresses); internal validation (internal consistency, verification, addresses 
whether or not the model behaves as intended and has been implemented correctly); cross 
validation (convergent validity, model results are confirmed by other models); external 
validation (model results predict outcomes obtained in a real world setting or in a dataset 
different from the one used for model development); predictive validation (model-predicted 
events are later corroborated by real-world observations).7,20  
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4. Mathematical modelling studies in guideline development 
In addition to providing a useful common terminology for public health specialists and 
mathematical modellers, the description of different model types and other terms defined in 
the glossary facilitate interpretation of the results of mathematical modelling studies and 
inform their incorporation into the guideline development process. As a first step, one needs 
to identify whether a particular research question, e.g., the evaluation of public health 
programmes, long-term effectiveness or comparative effectiveness, can be investigated using 
a model. Next, it will be necessary to assess whether existing mathematical modelling studies 
are appropriate to inform or support a research question or recommendation. We identified 
four comprehensive frameworks of good modelling practice.21 These frameworks cover items 
such as relevance, conceptualisation of the problem or model structure. Questions such as 
whether the model population is relevant, the variables represent the desired health outcomes, 
the necessary heterogeneity is taken into consideration, the time horizon is appropriate, or the 
assumptions are justified can help in the assessment of mathematical modelling studies. Other 
items concern validity or consistency, i.e., the performance of the model according to its 
specifications. The model should also consider uncertainty with regard to the structure, 
parameters and methods. Finally, credibility, which takes a number of these items into 
account, can then be used as the central concept for guideline developers to address the 
appropriateness of a mathematical modelling study for providing evidence for a specific 
question,22 as illustrated in the following example.   
Prevention of TB transmission in hospitals, and particularly of multidrug-resistant TB, is 
essential in all countries and requires a combination of strategies. Predicting the spread of TB 
in a hospital and the surrounding community, and how alternative methods of control might 
limit the emergence of resistance, are complex non-linear processes. It is, however, ethically 
and logistically impossible to conduct RCTs to examine the efficacy of these strategies. 
Mathematical modelling studies that use observational evidence can therefore play an 
important role in deciding which strategies are likely to be the most effective. The WHO 
guideline development group for TB infection control in health-care facilities, congregate 
settings and households assessed systematic reviews of the evidence, which included 
mathematical modelling studies.3  
One mathematical modelling study that the guideline committee considered investigated the 
effects of several different control measures on the spread of extensively drug resistant 
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(XDR) TB in a community in South Africa.10 The model described the transmission of TB in 
a complex system that included variables representing or contributing to: both a hospital and 
the surrounding community; different TB health states such as susceptible, latent, infectious 
and recovered; drug resistance; HIV infection; and the effects of different control 
interventions alone and in combination. Hence, the study considered the transmission setting 
that was of relevance to the guideline and the model structure included the desired health 
outcomes and variables. The authors used a mechanistic approach to make explicit the way in 
which stages in the transmission and natural history of TB are related. A deterministic, 
compartmental model, using ordinary differential equations to describe the transitions 
between different health states in a dynamic way was appropriate because it allowed the right 
balance between complexity and tractability. Key parameters that described the natural 
history, such as rate of natural clearance and rate of relapse were based on the literature and 
their influence was assessed in an uncertainty analysis. Parameters such as the 
transmissibility coefficient were calibrated using longitudinal data of individuals in a South 
African community, where data on TB were collected. The model outputs provided 
quantitative predictions about the percentage reduction in XDR-TB cases over a reasonable 
time horizon. External validation of the model was performed using cross-sectional data with 
information on the prevalence of TB and of drug resistance and the proportion of resistance 
cases in people with HIV infection. In summary, the mathematical modelling study covered 
many of the critical items and we would conclude that the study has a high credibility. 
Compared to natural ventilation, the authors found that mechanical ventilation alone would 
reduce XDR-TB cases by 12% (range 10-25%). The use of respiratory masks by health 
workers would prevent 2% of all TB cases, but nearly two-thirds of XDR cases in hospital 
staff. The guideline development group considered this study together with other 
observational and modelling studies identified through the systematic review. Even though 
the summarised evidence for the use of ventilation systems and particulate respirators was 
weak, indirect and of low quality, the studies suggested that these interventions are 
favourable for TB infection control. 
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Table 1. Model dichotomies describing the scope of, and approaches to, mathematical models in infectious 
disease epidemiology.  
Model dichotomy* Brief definition Example   Potential relevance or 
use for systematic 
review or guideline 
development  
Mechanistic 
vs. 
Uses mathematical 
terms to explicitly 
describe the 
mechanisms of infection 
transmission, 
pathogenesis and control 
measures.  
 
 
Compartmental model 
that describes the 
transmission of 
influenza and the effects 
of vaccination in 
England and Wales.23 
 
 
Allows implementation 
and modelling of 
different vaccination 
scenarios, such as 
targeting children or 
elderly. 
Phenomenological Uses mathematical 
terms to describe the 
interrelationships 
between risks and 
outcomes without 
making assumptions 
about the underlying 
mechanisms. 
 
Estimation and 
Projection Package 
(EPP) that fits a simple 
epidemic curve to HIV 
surveillance data.24  
Cannot be used to 
describe intervention 
effects in detail, so it is 
less likely to investigate 
hypothetical scenarios 
or interventions. 
Predictive 
vs. 
Forecasts future events . Impact projections of 
malaria vaccine for 
timeframes longer than 
previously conducted 
trials.25  
To investigate the 
expected future impact 
of implementing or 
changing interventions, 
and to set new targets . 
Descriptive Describes and/or 
explains previously 
observed phenomena. 
Quantifying the effect of 
malaria disease control 
efforts in Africa 
between 2000 and 
2015.2326 
 
To assess the 
effectiveness of past 
interventions or explain 
previous events and 
learn from them. 
 
Quantitative 
vs. 
Provides a precise 
numerical estimation or 
the expected range of an 
effect. 
HIV prevalence after 
expanding access to 
antiretroviral therapy.15  
To obtain estimates of 
an effect that can be 
incorporated into 
economic (cost-
effectiveness) analyses. 
Qualitative Describes the direction 
or general size of an 
effect. 
Increasing herpes zoster 
incidence after mass 
childhood vaccination 
against varicella.27 
Could indicate how and 
under what conditions 
an intervention could 
cause a specific 
epidemiological 
outcome. Might 
influence conditions of a 
recommendation. 
 
Theory-driven 
vs. 
Results are driven by 
theory/assumptions 
Investigating the 
theoretical strategy of 
universal testing and 
immediate treatment for 
HIV.28  
Can provide a rationale 
for considering a 
particular intervention. 
In the absence of data, 
results need to be 
critically evaluated in 
light of modelling 
assumptions.  
Data-driven Results are inferred Influenza transmission Can be used to assess 
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from data model to estimate the 
effectiveness of 
historical vaccination 
programmes.23  
effectiveness of 
interventions where 
randomised controlled 
trials are not possible. 
Evidence primarily 
relies on the quality of 
the primary data.  
 
* Some of these dichotomies are adapted from Bolker, 2008.29   
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